From receptor to nucleus: The Smad pathway

Current Opinion in Genetics and Development

Volumn 7, Issue 4, 1997, Pages 467-473

  Baker, Julie C ^a   Harland, Richard M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; CARBOXY TERMINAL SEQUENCE; CELL SPECIFICITY; EMBRYO; EMBRYO CELL; EMBRYO DEVELOPMENT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030775109     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80072-X     Document Type: Article

References (50)

1. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:1994;133-146.
2. Jones CM, Lyons KM, Lapan PM, Wright CV, Hogan BL. DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus mesoderm induction. Development. 115:1992;639-647.
3. Dale L, Howes G, Price BM, Smith JC. Bone morphogenetic protein 4: a ventralizing factor in early Xenopus development. Development. 115:1992;573-585.
4. Green JB, New HV, Smith JC. Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell. 71:1992;731-739.
5. Green JB, Smith JC. Graded changes in dose of a Xenopus activin A homologue elicit stepwise transitions in embryonic cell fate. Nature. 347:1990;391-394.
6. Mathews LS, Vale WW. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell. 65:1991;973-982.
7. Mathews LS, Vale WW, Kintner CR. Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Science. 255:1992;1702-1705.
8. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell. 68:1992;775-785.
9. Liu F, Ventura F, Doody J, Massagué J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol. 15:1995;3479-3486.
10. Ten Dijke P, Ichijo H, Franzen P, Schulz P, Saras J, Toyoshima H, Heldin CH, Miyazono K. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene. 8:1993;2879-2887.
11. Ten Dijke P, Yamshita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem. 269:1994;16985-16988.
12. Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R. Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science. 260:1993;1344-1348.
13. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of the TGF-beta receptor. Nature. 370:1994;341-347.
14. Attisano L, Wrana JL, Montalvo E, Massagué J. Activation of signalling by the activin receptor complex. Mol Cell Biol. 16:1996;1066-1073.
15. Willis SA, Zimmerman CL, Li L, Mathews LS. Formation and activation by phosphorylation of activin receptor complexes. Mol Endocrinol. 10:1996;367-379.
16. Wieser R, Wrana JL, Massague J. GS domain mutations that constitutively activate TβR-1 the downstream signalling component in the TGFβ receptor complex. EMBO J. 14:1995;2199-2208.
17. Chang C, Wilson PA, Mathews LS, Hemmati-Brivanlou A. A Xenopus type I activin receptor mediates mesodermal but not neural specification during embryogenesis. Development. 124:1997;827-837.
18. Ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, Heldin CH. Characterization of type I receptors for transforming growth factor-beta and activin. Science. 264:1994;101-104.
19. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM. Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics. 139:1995;1347-1358.
20. Raftery LA, Twombly V, Wharton K, Gelbart WM. Genetic screen to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics. 139:1995;241-254.
21. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L, Wrana JL. Madr1, a MAD-related protein that functions in BMP2 signaling pathways. of special interest Cell. 85:1996;489-500 Epistasis experiments show that Mad functions downstream of Dpp receptors and is required for receptor signaling. The authors identify Smad1, a vertebrate homolog of Mad, and show that Smad1 accumulates in the nucleus and becomes phosphorylated in reponse to BMP2.
22. Wiersdorff V, Lecuit T, Cohen SM, Mlodzik M. Mad acts downstream of Dpp receptors, revealing a differential requirement for Dpp signaling in initiation and propagation of morphogenesis in the Drosophila eye. Development. 122:1996;2153-2162.
23. Savage C, Das P, Finelli A, Townsend S, Sun C, Baird S, Padgett R. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components. of special interest Proc Natl Acad Sci USA. 93:1996;790-794 Identification of C. elegans genes, sma-2, sma-3 and sma-4, which have similar mutant phenotypes to those of daf-4, indicating that they are involved in TGF-β signaling. sma-2 is shown to function in the same cells as daf-4.
24. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM, Massagúe J. Human Smad1, a mediator of BMP signals, is a transcriptional activator. of outstanding interest Nature. 381:1996;620-623 Smad1 is here shown to have transcriptional activity when fused to a heterologous DNA-binding domain; this activity is increased by the addition of BMP4 AND BMP type I and type II receptors. The carboxy-terminal domain of Smad1 is shown to be important in transcriptional activation. Overexpression of Smad1 in Xenopus ectoderm induces the formation of ventral mesoderm.
25. Baker JC, Harland RM. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. of outstanding interest Genes Dev. 10:1996;1880-1889 Mouse Smad2 is here identified by expression cloning in the Xenopus ectoderm. Smad2 induces mesoderm from Xenopus ectoderm and can induce a secondary axis. Smad2 translocates into the nucleus in response to activin signaling. The carboxy-terminal domain of Smad2 translocates into the nucleus independently of activin signaling and is more potent at inducing mesoderm than the full-length protein.
26. Graff JM, Bansal A, Melton DA. Xenopus mad proteins transduce distinct subsets of signals for the TGF-β Superfamily. of special interest Cell. 85:1996;479-487 Identification and functional analysis of Xenopus Smad1 and Smad2. Smad1 is shown to induce ventral mesoderm from Xenopus ectoderm, whereas Smad2 is shown to induce dorsal mesoderm from Xenopus ectoderm.
27. Thomsen GH. Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP 2/4 receptor. Development. 122:1996;2359-2366.
28. Suzuki A, Chang C, Yingling JM, Wang XF, Hemmati-Brivanlou A. Smad5 induces ventral fates in Xenopus embryos. Dev Biol. 184:1997;402-405.
29. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. Partnership between DPC4 and SMAD proteins in TGF-beta signaling pathways. of outstanding interest Nature. 383:1996;832-836 DPC4 is essential for the function of Smad1 and Smad2 during transcriptional responses in mammalian cells and in Xenopus mesodermal induction and patterning. DPC4 forms heterodimers with Smad1 in response to BMP and with Smad2 in response to activin or TGF-β.
30. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, et al. Madr2 maps to 18q21 and encodes a TGF-β-regulated Mad-related protein that is functionally mutated in colorectal carcinoma. of special interest Cell. 86:1996;543-552 Smad2 is shown to be phosphorylated by TGF-β signaling. Mutational analysis of Smad2 in tumor cells identified four missense mutations in colorectal carcinomas.
31. Yingling JM, Das P, Savage C, Xhang C, Padgett RW. Mammalian dwarfins are phosphorylated in response to TGF-β and are implicated in control of cell growth. Proc Natl Acad Sci USA. 93:1996;8940-8944.
32. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling. of outstanding interest Cell. 87:1996;1215-1224 Three serines in the carboxyl terminus of Smad2 are shown to be critical for phosphorylation, nuclear localization and TGF-β signaling. Smad2 is shown to interact with receptors transiently and requires the activation of the type I receptor by the type II receptor.
33. Kretzschmar M, Liu F, Hata A, Doody J, Massagué J. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. of outstanding interest Genes Dev. 11:1997;984-995 Smad1 contains three carboxy-terminal serines that are essential for phosphorylation, association with DPC4, accumulation in the nucleus, and transcriptional activity in response to BMP signaling. Smad2, but not DPC4, has similar carboxy-terminal serines which are required for phosphorylation and association with DPC4 in response to TGF-β signaling.
34. Zhang Y, Feng X-H, Wu RY, Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. of special interest Nature. 383:1996;168-172 Identification and analysis of Smad3 and Smad4, which are shown to synergize to induce TGF-β-like responses in mammalian cells. Smad3 associates with and is phosphorylated by the TGF-β receptor complex.
35. Chen X, Rubock MJ, Whitman M. A transcriptional partner for MAD proteins in TGF-β signalling. of outstanding interest Nature. 383:1996;691-696 FAST-1 is identified as a winged-helix transcription factor which interacts with the ARE in the Mix.2 promoter. FAST-1 forms a complex with Smad2 in an activin-dependent fashion that generates an ARE-binding complex.
36. Holley SA, Jackson PD, Sasai Y, Lu B, De Robertis EM, Hoffman FM, Ferguson EL. A conserved system for dorsal-ventral patterning in insects and vertebrates involving sog and chordin. Nature. 376:1995;249-253.
37. Padgett RW, Wozyney JM, Gelbart GM. Human BMP sequences can confer normal dorsal-ventral patterning in the Drosophila embryo. Proc Natl Acad Sci USA. 90:1993;2905-2909.
38. Massagué J, Weis-Garcia F. Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv. 27:1996;41-64.
39. Letsou A, Arora K, Wrana J, Simin K, Twombly V, Jamal J, Staehling-Hampton K, Hoffman FM, Gelbert WM, Massagué J, O'Conner MB. Dpp signaling in Drosophila is mediated by the punt gene product: a dual ligand-binding type II receptor of the TGF-β receptor family. Cell. 80:1995;899-908.
40. Ruberte E, Marty T, Nellen D, Affolter M, Basler K. An absolute requirement for both the type II and type I receptors, Punt and Thickveins for dpp signaling in vivo. Cell. 80:1995;889-897.
41. Koenig BB, Cook JS, Wolsing DH, Ting J, Tiesman JP, Correa PE, Olson CA, Pecquet AL, Ventura F, Grant RA, et al. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH3T3 cells. Mol Cell Biol. 14:1994;5961-5974.
42. Nohno T, Ishikawa T, Saito T, Hosokawa K, Noji S, Wolsing DH, Rosenbaum JS. Identification of a human type II receptor for bone morphogenetic-4 that forms differential heteromeric complexes with bone morphogenic protein type I receptors. J Biol Chem. 270:1995;22522-22526.
43. Attisano L, Wrana JL, Montalvo E, Massagué J. Activation of signalling by the activin receptor complex. Mol Cell Biol. 16:1996;1066-1073.
44. Penton A, Chen Y, Staehling-Hampton K, Wrana JL, Attisano L, Szidonya J, Cassil A, Massagué J, Hoffman FM. Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell. 78:1994;239-250.
45. Franzen P, ten Dijke P, Ichijo H, Yamashinta H, Schulz P, Heldin C-H, Miyazono K. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell. 75:1993;681-692.
46. Attisano L, Wrana JL, Cheifetz S, Massagué J. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoir of serine/threonine kinase receptors. Cell. 68:1992;97-108.
47. Newfield SJ, Chartoff EH, Graff JM, Melton DA, Gelbart WM. Mothers against dpp encodes a conserved cytoplasmic protein required in dpp/TGF-β responsive cells. Development. 122:1996;2099-2108.
48. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA. 92:1995;7632-7636.
49. Estevez M, Attisano L, Wrana JL, Albert PS, Massagué J, Riddle DL. The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature. 365:1993;644-649.
50. Georgi LL, Albert PS, Riddle DL. Daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase. Cell. 61:1990;635-645.